Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos.
<h4>Background</h4>Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which can be large. Participants in trials can misunderstand written information particularly regarding technical aspects of trial design such as randomisation; the adequacy of...
Main Authors: | Felicity L Bishop, Alison E M Adams, Ted J Kaptchuk, George T Lewith |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22761859/pdf/?tool=EBI |
Similar Items
-
Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos
by: Bishop, Felicity L., et al.
Published: (2012) -
P05.35. What are participants in clinical trials told about placebos? A content analysis of participant information leaflets
by: Bishop F, et al.
Published: (2012-06-01) -
Participants' experiences of being debriefed to placebo allocation in a clinical trial
by: Bishop, Felicity L., et al.
Published: (2012) -
The definition of placebo in the informed consent forms of clinical trials.
by: Astrid Hernández, et al.
Published: (2014-01-01) -
Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture
by: Soyeon Cheon, et al.
Published: (2018-01-01)